Rey, JW; Schreiner, O; Barreiros, AP et al.
Acute Renal and Liver Dysfunction after Subcutaneous Injection of 3-sn-Phosphatidylcholine (Lipostabil (R)) - Case ReportZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 49. H. 3. 2011 S. 340-343
Kittner, JM; Sprinzl, MF; Grambihler, A et al.
ADD-ON OF PEG-INTERFERON TO A STABLE NUCLEOS(T)IDE REGIMEN LEADS TO LOSS OF HBS-AG IN PATIENTS WITH CHRONIC HEPATITIS BJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S291-S291
Heinrich, S; Pestalozzi, B; Lesurtel, M et al.
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)BMC CANCER. Bd. 11. 2011 S. -
Ben M'Barek, M; Volz, T; Lutgehetmann, M et al.
ADMINISTRATION OF THE ENTRY INHIBITOR MYRCLUDEX-B AFTER ESTABLISHMENT OF HEPATITIS B VIRUS INFECTION PREVENTS VIRAL SPREADING AMONG HUMAN HEPATOCYTES IN UPA MICEJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S33-S33
Gamstatter, T; Weinmann, A; Schadmand-Fischer, S et al.
AFP Measurement in Monitoring Treatment Response of Advanced Hepatocellular Carcinoma to Sorafenib: Case Report and Review of the LiteratureONKOLOGIE. Bd. 34. H. 10. 2011 S. 538-542
Schmaderer, C; Xing, CJ; Anderson, G et al.
AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathyLIFE SCIENCES. Bd. 89. H. 11-12. 2011 S. 349-354
Moehler, M; Muller, A; Hartmann, JT et al.
An open-label, multicenter biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancerONKOLOGIE. Bd. 34. 2011 S. 103-103
Moehler, M; Mueller, A; Hartmann, JT et al.
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancerEUROPEAN JOURNAL OF CANCER. Bd. 47. H. 10. 2011 S. 1511-1520
Stallmach, A; Schmidt, C; Watson, A et al.
An unmet medical need: Advances in endoscopic imaging of colorectal neoplasiaJOURNAL OF BIOPHOTONICS. Bd. 4. H. 7-8. 2011 S. 482-489
Atreya, R; Zimmer, M; Bartsch, B et al.
Anti-TNF Antibodies Target T-Cell Apoptosis in Inflammatory Bowel Diseases via the mTNF/TNFR2 Signalling PathwayGASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S838-S838